Press-release for stocks related to europe

| 47.54% | O: 70.49% H: 0.0% C: 0.0%
europe worldwide commercialization therapeutics

Acer Therapeutics Reacquires Worldwide Development, Commercialization and Economic Rights to OLPRUVA™ from Relief Therapeutics, Excluding the Geographical Europe
Published: 2023-08-30 (Crawled : 20:00) - globenewswire.com
ACER | $0.9 -3.61% 420K

| 47.54% | O: 70.49% H: 0.0% C: 0.0%
europe worldwide commercialization therapeutics

Novocure Announces Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint
Published: 2023-01-05 (Crawled : 13:00) - biospace.com/
NVCR | $11.95 -0.83% 460K

| -82.92% | O: 53.35% H: 10.97% C: 9.85%
lung cancer study

La Jolla Pharmaceutical Company Announces Exclusive Licensing Agreement for GIAPREZA™ (Angiotensin II) and XERAVA™ (Eravacycline) in Europe
Published: 2021-01-12 (Crawled : 15:00) - biospace.com/
LJPC | $6.22 0.0%

| 57.61% | O: 49.75% H: 5.76% C: -14.58%
license europe

Relief Reports that its U.S. Collaboration Partner has Announced Progress on Worldwide Commercial Scale Development of ZYESAMI(TM) (aviptadil)
Published: 2021-10-13 (Crawled : 09:00) - biospace.com/
NRXP | $3.065 1.49% 210K

| -55.26% | O: 43.85% H: 2.99% C: -2.78%
collaboration aviptadil commercialization

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits
Published: 2023-04-19 (Crawled : 12:20) - biospace.com/
VRAX | $0.661 -2.75% 5.9K

| 12.68% | O: 40.99% H: 0.39% C: -34.19%
marburg distribution group virus agreement

Relief Therapeutics to Participate in Virtual Investor Conferences in January 2022
Published: 2022-01-05 (Crawled : 12:00) - biospace.com/
RLFTF | $1.43 3.8K

| 1613.59% | O: 30.48% H: 11.16% C: 6.0%
RLFTY | $1.4006 733.33% 100

| -88.43% | O: 39.14% H: 3.86% C: 3.26%
conference therapeutics

Stealth BioTherapeutics Receives Orphan Drug Designation from the European Medicines Agency for Elamipretide for the Treatment of Barth Syndrome
Published: 2021-06-01 (Crawled : 21:00) - prnewswire.com
MITO | $0.32 0.25%

| -77.93% | O: 38.62% H: 4.48% C: -11.94%
treatment europe drug iot syndros elamipretide designation

Venus Concept Announces CE Mark for Venus Versa Pro in Europe
Published: 2024-02-22 (Crawled : 12:30) - globenewswire.com
VERO | $0.85 1.19% 13K

| -36.89% | O: 37.7% H: 31.85% C: 10.71%
europe pro

Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
Published: 2023-09-01 (Crawled : 10:00) - biospace.com/
RLFTF | $1.43 3.8K

| -55.27% | O: 22.68% H: 7.81% C: 0.0%
RLFTY | $1.4006 733.33% 100

| -47.35% | O: 34.59% H: 6.59% C: 6.59%
conference global therapeutics

Freeline Announces FDA Clearance of Investigational New Drug Application for FLT201 for Gaucher Disease Type 1
Published: 2022-01-06 (Crawled : 20:00) - biospace.com/
FRLN | $6.48 0.0% 0

Professional, Scientific, and T...

| 230.61% | O: 32.65% H: 1.15% C: -23.85%
flt201 new drug fda clearance application drug disease fda clearance

Elvictor Group Inc. Receives Gold Award for the Second Consecutive Year from the European Business Ethics Network for Ethos and Social Responsibility
Published: 2021-12-20 (Crawled : 23:00) - globenewswire.com
ELVG | $0.0125 225.6% 50K

| -60.94% | O: 24.38% H: 0.0% C: -22.11%
europe pons group

PLAY’s new low-cost route between Europe and New York
Published: 2022-02-01 (Crawled : 08:00) - globenewswire.com
ARVL | News | $0.49 0.37% 2.5M

| -83.48% | O: 22.52% H: 0.0% C: 0.0%
europe

TC BioPharm Announces FDA Clearance of Phase 1B IND for TCB-008 in Acute Myeloid Leukemia
Published: 2023-11-27 (Crawled : 14:30) - biospace.com/
TCBP | $1.46 2.82% 73K

| -87.41% | O: 22.36% H: 0.0% C: -39.13%
tcb-008 fda clearance leukemia

Relief Reports that its U.S. Collaboration Partner has Announced Successful Commercial Formulation for Aviptadil
Published: 2021-07-23 (Crawled : 09:00) - biospace.com/
NRXP | $3.065 1.49% 210K

| -81.64% | O: 22.31% H: 0.0% C: 0.0%
collaboration aviptadil commercialization

Vifor Pharma and Cara Therapeutics announce U.S. FDA approval of KORSUVA™ injection for the treatment of moderate-to-severe pruritus in hemodialysis patients
Published: 2021-08-24 (Crawled : 07:00) - biospace.com/
CARA | $0.6665 -3.41% 250K

| -95.17% | O: 21.08% H: 5.55% C: -13.94%
treatment fda hemodialysis fda approval injection approval

Exscientia Announces AI Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany
Published: 2023-09-20 (Crawled : 09:00) - biospace.com/
EXAI | $4.19 -3.9% 280K

| -13.83% | O: 20.95% H: 0.0% C: -25.98%
drug merck germany collaboration

LumiraDx receives approval for its COVID-19 Antigen Test for use in India
Published: 2021-10-20 (Crawled : 21:00) - biospace.com/
LMDX | $0.016 -15.0% 130M

| -99.81% | O: 20.4% H: 3.25% C: -6.7%
covid test india approval covid-19

AgriFORCE Growing Systems Signs Definitive Agreement to Acquire Delphy, a Leading European Agriculture/Horticulture and AgTech Consulting Firm
Published: 2022-02-15 (Crawled : 14:00) - globenewswire.com
AGRI | $0.149 -0.73% 820K

| -90.65% | O: 20.38% H: 7.94% C: -7.41%
europe system growing

Endo Announces Agreement with Premier to Supply VASOSTRICT® (vasopressin injection, USP) Vials, Essential for COVID-19 Care
Published: 2021-11-08 (Crawled : 13:15) - biospace.com/
ENDP | $0.2926 -9.6%

| -94.53% | O: 17.07% H: 6.49% C: 2.02%
covid injection

← Previous
1
2
3
4
5
6
7
8
9
…
119
120
Next →

Gainers vs Losers

71%

29%

Top 10 Gainers

AGBA | News | $1.27 217.5% 120M

Finance

EGOX | $0.0503 39.72% 320M

RWOD | $10.52 31.56% 5.9M

ZCMD | $1.905 31.38% 30M

Commercial Services

MRDB 4 | $0.536 27.65% 2M

BSFC | $0.0822 27.64% 75M

TPET | $0.4121 25.68% 45M

NVFY | $2.65 25.59% 33M

Consumer Durables

INDO | $5.1 25.0% 15M

Energy Minerals

CHRO | $1.53 24.9% 100K